NIFTY 50

COVID-19: Gujarat-based Supreme Industries gets nod for human trials of inhalation therapy

Updated : April 07, 2021 10:47:32 IST

Gujarat-based Supreme Industries has received the drug regulator's go-ahead to conduct phase-one human trials for its inhalation therapy to treat COVID-19.

The therapy, called LifeViroTreat, has been developed in collaboration with Hyderabad-based Lifeactivers. Timsy Jaipuria reports that this is a 3-day inhalation therapy and the company claims that it can completely kill the COVID-19 virus from the respiratory tract.

The company had submitted animal trial data to the subject expert committee (SEC) and had said that this is a chlorine gas product administered in 1mg doses and involves two dose nebulisation or inhalation for three days.

Watch video for more.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you